Xylem (XYL) Tops Q1 EPS by 10c, Revenues Beat; Raises FY21 EPS Guidance

Go back to Xylem (XYL) Tops Q1 EPS by 10c, Revenues Beat; Raises FY21 EPS Guidance

Goldman Sachs Upgrades Xylem (XYL) to Neutral

May 5, 2021 9:15 AM EDT

Goldman Sachs analyst Brian Lee upgraded Xylem (NYSE: XYL) from Sell to Neutral with a price target of $107.00 (from $73.00).

The analyst comments "We acknowledge that our negative call here has been wrong, as we believed the company had more revenue downside risk... More